← Back to News

Various

Analyst Upgrades and Downgrades For the Week of August 19th

Analyst upgrades, downgrades, and more

By Justin Nugent · August 20, 2024
Analyst Upgrades and Downgrades For the Week of August 19th

Friday, August 23rd

Upgrades

  • Bilibili (BILI): Barclays upgraded from Equal Weight to Overweight with a price target increase from $14 to $19.
  • BJ’s Wholesale (BJ): Wells Fargo upgraded from Equal Weight to Overweight, raising the price target from $75 to $92.
  • Gaming and Leisure Properties (GLPI): Wolfe Research upgraded from Peer Perform to Outperform with a price target of $57.
  • Hawaiian Electric (HE): Wells Fargo upgraded from Underweight to Equal Weight with a price target of $14.
  • Roku (ROKU): Guggenheim upgraded from Neutral to Buy with a price target of $75.
  • Snowflake (SNOW): HSBC Securities upgraded from Reduce to Hold, raising the price target from $119 to $121.
  • BBB Foods (TBBB): HSBC Securities upgraded from Reduce to Hold with no change in the price target of $31.
  • Westlake Corporation (WLK): RBC Capital Markets upgraded from Sector Perform to Outperform, increasing the price target from $157 to $174.
  • Warby Parker (WRBY): JMP Securities upgraded from Market Perform to Market Outperform, raising the price target to $20.
  • Lyft (LYFT): Nomura upgraded from Reduce to Neutral.

Downgrades

  • Bill.com (BILL): Goldman downgraded from Buy to Neutral with a price target reduction from $86 to $54.
  • iQIYI (IQ): The Benchmark Company downgraded from Buy to Hold.
  • KORE Group (KORE): TD Cowen downgraded from Buy to Hold with a price target of $2.
  • Las Vegas Sands (LVS): UBS downgraded from Buy to Neutral, cutting the price target from $70 to $49.
  • Topgolf Callaway Brands (MODG): Raymond James downgraded from Outperform to Underperform.
  • Peloton (PTON): JP Morgan downgraded from Overweight to Neutral, reducing the price target from $7 to $5.
  • Baidu (BIDU): Bernstein downgraded from Outperform to Market Perform, lowering the price target from $130 to $97.

Coverage Initiated

  • Smurfit Westrock plc (SW): Redburn Atlantic initiated coverage with a Buy rating and a price target of $60.
  • Varex Imaging (VREX): B. Riley Securities initiated coverage with a Buy rating and a price target of $21.

Coverage Resumed

  • Autodesk (ADSK): Morgan Stanley resumed coverage with an Overweight rating and a price target of $305.
  • Chewy (CHWY): Piper Sandler resumed coverage with an Overweight rating and a price target of $35.
  • Crocs (CROX): Piper Sandler resumed coverage with an Overweight rating and a price target of $170.
  • Deckers Outdoor (DECK): Piper Sandler resumed coverage with a Neutral rating and a price target of $1000.
  • EQT Corp. (EQT): Citigroup resumed coverage with a Neutral rating and a price target of $37.
  • Etsy (ETSY): Piper Sandler resumed coverage with a Neutral rating and a price target of $56.
  • Foot Locker (FL): Piper Sandler resumed coverage with a Neutral rating and a price target of $30.
  • lululemon athletica (LULU): Piper Sandler resumed coverage with a Neutral rating and a price target of $250.
  • NIKE (NKE): Piper Sandler resumed coverage with a Neutral rating and a price target of $80.
  • On (ONON): Piper Sandler resumed coverage with an Overweight rating and a price target of $52.
  • Revolve Group (RVLV): Piper Sandler resumed coverage with an Overweight rating and a price target of $30.
  • Steven Madden (SHOO): Piper Sandler resumed coverage with a Neutral rating and a price target of $45.
  • Warby Parker (WRBY): Piper Sandler resumed coverage with an Overweight rating and a price target of $18.
  • Wolverine (WWW): Piper Sandler resumed coverage with an Overweight rating and a price target of $18.
  • LifeMD (LFMD): B. Riley Securities initiated coverage with a Buy rating and a price target of $11.

Tuesday, August 20th

Upgrades

  1. Antero Resources (AR)
    • Brokerage Firm: Scotiabank
    • Ratings Change: Sector Perform to Sector Outperform
    • Price Target: $44
  2. Braskem SA (BAK)
    • Brokerage Firm: Citigroup
    • Ratings Change: Neutral to Buy
  3. BioMarin Pharmaceutical (BMRN)
    • Brokerage Firm: Bernstein
    • Ratings Change: Market Perform to Outperform
    • Price Target: $94 to $110
  4. Banco Santander Chile (BSAC)
    • Brokerage Firm: Goldman Sachs
    • Ratings Change: Sell to Neutral
    • Price Target: $18 to $21
  5. Range Resources (RRC)
    • Brokerage Firm: Scotiabank
    • Ratings Change: Sector Perform to Sector Outperform
    • Price Target: $45
  6. FUJIFILM (FUJIY)
    • Brokerage Firm: Jefferies
    • Ratings Change: Hold to Buy
  7. Vornado Realty Trust (VNO)
    • Brokerage Firm: Evercore ISI
    • Ratings Change: Underperform to Outperform
  8. SFL Corporation (SFL)
    • Brokerage Firm: Pareto
    • Ratings Change: Hold to Buy

Downgrades

  1. AbCellera Biologics (ABCL)
    • Brokerage Firm: The Benchmark Company
    • Ratings Change: Buy to Hold
  2. Alight (ALIT)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight to Neutral
    • Price Target: $8
  3. AvidXchange (AVDX)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight to Neutral
    • Price Target: $11 to $9
  4. Bancolombia S.A. (CIB)
    • Brokerage Firm: Goldman Sachs
    • Ratings Change: Neutral to Sell
    • Price Target: $34 to $32
  5. JPMorgan Chase (JPM)
    • Brokerage Firm: Daiwa Securities
    • Ratings Change: Buy to Outperform
    • Price Target: $240
  6. Stride (LRN)
    • Brokerage Firm: Citigroup
    • Ratings Change: Buy to Neutral
    • Price Target: $77 to $90
  7. Woodside Energy Group (WDS)
    • Brokerage Firm: Bernstein
    • Ratings Change: Outperform to Market Perform
  8. Cousins Properties (CUZ)
    • Brokerage Firm: Evercore ISI
    • Ratings Change: Outperform to In-line
    • Price Target: $29
  9. Vontier (VNT)
    • Brokerage Firm: Argus
    • Ratings Change: Buy to Hold
  10. Globant (GLOB)
    • Brokerage Firm: UBS
    • Ratings Change: Buy to Neutral
  11. Genmab (GMAB)
    • Brokerage Firm: JP Morgan
    • Ratings Change: Overweight to Neutral
  12. Titan Machinery (TITN)
    • Brokerage Firm: Northland Capital
    • Ratings Change: Outperform to Market Perform
  13. Agora (API)
    • Brokerage Firm: BofA Securities
    • Ratings Change: Buy to Neutral
    • Price Target: $4 to $2.63

Coverage Initiated

  1. Advanced Micro Devices (AMD)
    • Brokerage Firm: Edward Jones
    • Rating: Buy
  2. Concentra Group Holdings Parent (CON)
    • Brokerage Firm: RBC Capital Markets
    • Rating: Outperform
    • Price Target: $33
  3. MediaAlpha (MAX)
    • Brokerage Firm: Goldman Sachs
    • Rating: Buy
    • Price Target: $20
  4. Sonic Automotive (SAH)
    • Brokerage Firm: Needham
    • Rating: Buy
    • Price Target: $73
  5. Vista Energy (VIST)
    • Brokerage Firm: JP Morgan
    • Rating: Overweight
    • Price Target: $68
  6. Lineage Cell Therapeutics (LCTX)
    • Brokerage Firm: Craig Hallum
    • Rating: Buy
    • Price Target: $4
  7. ARS Pharmaceuticals (SPRY)
    • Brokerage Firm: Cantor Fitzgerald
    • Rating: Overweight

Monday, August 19th

Upgrades (Monday, August 19, 2024)

  • Banco Bradesco (BBD): Goldman
    • Rating Change: Neutral to Buy
    • Price Target: $2.50 to $3.20
  • Burlington Stores (BURL): Gordon Haskett
    • Rating Change: Hold to Buy
    • Price Target: $300
  • Gates Industrial (GTES): RBC Capital Markets
    • Rating Change: Sector Perform to Outperform
    • Price Target: $20 to $22
  • Taylor Morrison Home (TMHC): BTIG Research
    • Rating Change: Neutral to Buy
    • Price Target: $78
  • CareDx (CDNA): BTIG Research
    • Rating Change: Neutral to Buy
    • Price Target: $40
  • Newmont Corporation (NEM): Scotiabank
    • Rating Change: Sector Perform to Sector Outperform
    • Price Target: $48 to $59
  • Mercury (MRCY): Alembic Global Advisors
    • Rating Change: Neutral to Overweight
  • Onto Innovation (ONTO): Needham
    • Rating Change: Hold to Buy
  • ArcelorMittal (MT): Barclays
    • Rating Change: Equal Weight to Overweight
  • Liquidia Technologies (LQDA): Raymond James
    • Rating Change: Outperform to Strong Buy

Downgrades (Monday, August 19, 2024)

  • Dutch Bros (BROS): Piper Sandler
    • Rating Change: Overweight to Neutral
    • Price Target: $41 to $36
  • HP Inc. (HPQ): Morgan Stanley
    • Rating Change: Overweight to Equal-Weight
    • Price Target: $37 (unchanged)
  • Terran Orbital (LLAP): H.C. Wainwright
    • Rating Change: Buy to Neutral
    • Price Target: $3 to $0.25
  • Shake Shack (SHAK): Piper Sandler
    • Rating Change: Overweight to Neutral
    • Price Target: $121 to $114
  • Sol-Gel (SLGL): Raymond James
    • Rating Change: Strong Buy to Outperform
    • Price Target: $6 to $4
  • AngloGold Ashanti (AU): Scotiabank
    • Rating Change: Sector Perform to Sector Underperform
    • Price Target: $27 to $30
  • Codexis (CDXS): The Benchmark Company
    • Rating Change: Buy to Hold
  • Chuy’s (CHUY): The Benchmark Company
    • Rating Change: Buy to Hold
    • Price Target: $37.50
  • Gogoro (GGR): The Benchmark Company
    • Rating Change: Buy to Hold
  • Hamilton Insurance Group, Ltd. (HG): Morgan Stanley
    • Rating Change: Overweight to Equal-Weight
    • Price Target: $19
  • Ulta Beauty (ULTA): Cleveland Research
    • Rating Change: Buy to Neutral
  • Sweetgreen (SG): Piper Sandler
    • Rating Change: Overweight to Neutral
    • Price Target: $33 to $39
  • Kimco Realty (KIM): Mizuho
    • Rating Change: Outperform to Neutral
  • Deere (DE): HSBC Securities
    • Rating Change: Buy to Hold
  • Himalaya Shipping Ltd. (HSHP): DNB Markets
    • Rating Change: Hold to Sell
  • fuboTV (FUBO): Seaport Research Partners
    • Rating Change: Buy to Neutral

Coverage Initiated (Monday, August 19, 2024)

  • Aligos Therapeutics (ALGS): H.C. Wainwright
    • Rating: Buy
    • Price Target: $75
  • Foghorn Therapeutics (FHTX): Evercore ISI
    • Rating: Outperform
    • Price Target: $20
  • Predictive Oncology (POAI): H.C. Wainwright
    • Rating: Buy
    • Price Target: $3
  • Pure Storage (PSTG): Piper Sandler
    • Rating: Neutral
    • Price Target: $60
  • Rubrik (RBRK): Piper Sandler
    • Rating: Overweight
    • Price Target: $42
  • Skyward Specialty Insurance Group (SKWD): William Blair
    • Rating: Outperform
  • OneStream (OS):
    • H.C. Wainwright: Outperform, Price Target: $32
    • Truist: Buy, Price Target: $35
    • Scotiabank: Sector Outperform, Price Target: $34
    • Wolfe Research: Outperform, Price Target: $32
    • Morgan Stanley: Equal-Weight, Price Target: $29
    • BTIG Research: Buy, Price Target: $37
    • Citigroup: Neutral, Price Target: $34
    • JP Morgan: Overweight, Price Target: $30
    • Needham: Buy, Price Target: $33
    • BofA Securities: Buy, Price Target: $35
    • TD Cowen: Buy, Price Target: $34
    • Loop Capital: Buy, Price Target: $35
    • Guggenheim: Buy
  • Lineage (LINE):
    • UBS: Neutral, Price Target: $88
    • Scotiabank: Sector Outperform, Price Target: $95
    • Evercore ISI: In-line, Price Target: $88
    • Truist: Buy, Price Target: $94
    • Wells Fargo: Equal Weight, Price Target: $86
    • Morgan Stanley: Overweight, Price Target: $100
    • Robert W. Baird: Outperform, Price Target: $91
    • Mizuho: Neutral, Price Target: $86
    • JP Morgan: Overweight, Price Target: $93
    • Goldman: Buy, Price Target: $105
  • Concentra Group Holdings Parent (CON):
    • Truist: Buy, Price Target: $29
    • Wells Fargo: Overweight, Price Target: $27
    • Mizuho: Outperform, Price Target: $28
    • Goldman: Buy, Price Target: $32
    • JP Morgan: Overweight, Price Target: $29
    • Deutsche Bank: Buy, Price Target: $29
    • BofA Securities: Buy
  • Apple (AAPL): MoffettNathanson
    • Rating: Neutral
    • Price Target: $211
  • Athira Pharma (ATHA): Rodman & Renshaw
    • Rating: Buy
    • Price Target: $22
  • HEICO (HEI): Barclays
    • Rating: Equal Weight
    • Price Target: $250
  • Lineage (LINE): Deutsche Bank
    • Rating: Hold
    • Price Target: $90
  • Lineage (LINE): Piper Sandler
    • Rating: Overweight
    • Price Target: $102
  • NETSTREIT (NTST): Wedbush
    • Rating: Neutral
  • Broadstone Net Lease (BNL): Wedbush
    • Rating: Outperform
  • Essential Properties Realty Trust (EPRT): Wedbush
    • Rating: Outperform
  • Realty Income (O): Wedbush
    • Rating: Neutral
  • Clearwater Analytics (CWAN): Citigroup
    • Rating: Buy
    • Price Target: $28